Larson Financial Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.63K Sell
104
-40
-28% -$3.76K ﹤0.01% 2432
2026
Q1
$12.8K Sell
144
-130
-47% -$13.4K ﹤0.01% 2098
2025
Q4
$26K Buy
274
+127
+86% +$12.8K ﹤0.01% 1571
2025
Q3
$14.5K Hold
147
﹤0.01% 1818
2025
Q2
$15.7K Hold
147
﹤0.01% 1598
2025
Q1
$13.4K Hold
147
﹤0.01% 1523
2024
Q4
$16.8K Hold
147
﹤0.01% 1281
2024
Q3
$17.5K Buy
147
+12
+9% +$1.1K ﹤0.01% 1270
2024
Q2
$10.8K Buy
135
+100
+286% +$9.14K ﹤0.01% 1241
2024
Q1
$3.23K Buy
+35
New +$3.36K ﹤0.01% 1277
2022
Q1
Sell
-4
Closed -$1K 1047
2021
Q4
$1K Buy
+4
New +$1.1K ﹤0.01% 998

Other funds holding BNTX

Larson Financial Group's BNTX Position: Q2 2026 in Review

Larson Financial Group reduced its BioNTech (BNTX) stake by 28% in Q2 2026, selling an estimated $3.76K and leaving 104 shares worth $9.63K. The position accounts for ﹤0.01% of the portfolio, ranked #2432.

Larson Financial Group first reported a position in BNTX in Q4 2021 and has held it in 11 quarters since. The position peaked at $26K in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Larson Financial Group held 104 shares of BioNTech worth $9.63K as of Q2 2026.
  • Larson Financial Group sold 40 BioNTech shares in Q2 2026, an estimated $3.76K.
  • BioNTech made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2432 holding.
  • Larson Financial Group first reported a position in BioNTech in Q4 2021 and has held it in 11 quarters since.
  • Larson Financial Group's BioNTech position peaked at $26K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.